The Search for New Cures Is Brokennews2026-09-04T11:27:49+00:00September 4th, 2026|The New York Times|
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugsnews2026-08-31T16:43:57+00:00August 31st, 2026|The New York Times|
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Manynews2026-08-27T09:02:45+00:00August 27th, 2026|The New York Times|
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancernews2026-08-26T16:54:01+00:00August 26th, 2026|The New York Times|
Moderna’s Shift to Cancer Company Lifts Stock Up 177%news2026-08-20T14:23:51+00:00August 20th, 2026|The New York Times|
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Researchnews2026-07-28T14:41:19+00:00July 28th, 2026|The New York Times|
Scientists Race to Test Treatments as Ebola Outbreak Widensnews2026-06-13T01:26:24+00:00June 13th, 2026|The New York Times|
As Ebola Spreads, Scientists Race to Find Vaccines and Treatmentsnews2026-06-02T01:38:21+00:00June 2nd, 2026|The New York Times|
China’s Rise in Drug Development Looms Over U.S.news2026-05-30T04:00:06+00:00May 30th, 2026|The New York Times|
